Tag Archives: AGU

Best Blue Chip Stocks To Invest In 2019

General Electric was blasted on Wednesday by workers, retirees and shareholders bemoaning the downfall of the company they love.

At its annual meeting, GE (GE) got an earful from employees and investors who pleaded with management to right the ship after a disastrous year.

“I believe it was arrogance and a series of bad business decisions,” former employee Bill Freeda said. “Our board of directors clearly has been AWOL.”

Another shareholder said: “GE, which was once one of the preeminent companies in the world — the bluest of blue chips — is now an embarrassment.”

The past 12 months has been one of the darkest periods in GE’s 126-year history. A cash crisis, brought on by years of bad deal-making, forced GE to cut its dividend in half and lay off thousands of workers. GE’s stock price has crashed by 50%, and calls to kick it out of the Dow have grown louder.

Despite the deep criticism of past and current GE leaders, the company’s nominees to the board were all elected on Wednesday. None of the shareholder proposals calling for reform were adopted, though one pushing for splitting the CEO and chairman roles received strong support.

Best Blue Chip Stocks To Invest In 2019: Agrium Inc.(AGU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news headlines that may have impacted Accern’s rankings:

    Get Agrium alerts:

    Addenda Capital Has Increased Agrium (AGU) Stake By $513880; Guidewire Software (GWRE) Shorts Lowered By … (mtastar.com) Toron Capital Markets Increased By $13.63 Million Its Agrium (AGU) Holding; Isoray (ISR) Has 9 Sentiment (mtastar.com) Global Liquid Potassium Thiosulfate Market 2018 – Agrium, RW Griffin, Plant Food, Hydrite Chemical (satprnews.com) Global NPK Market Analysis 2018 – K+S, Rossosh, Euro Chem, Agrium and Acron (theexpertconsulting.com) Global Controlled-release Fertilizers Market Study 2018-2025 Harrell’s, Agrium, Koch, Knox (assessmentofmarkets.com)

    Agrium traded up $0.41, hitting $115.00, on Friday, according to MarketBeat.com. 833,843 shares of the company’s stock were exchanged, compared to its average volume of 407,078. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.78 and a current ratio of 1.29. Agrium has a 52 week low of $87.82 and a 52 week high of $117.28.

Best Blue Chip Stocks To Invest In 2019: Vuzix Corporation(VUZI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get Vuzix alerts:

    VUZI LOSS NOTICE: Rosen Law Firm Reminds Vuzix Corporation Investors of Important Deadline In Class Action – VUZI (finance.yahoo.com) SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Vuzix Corporation of Class Action Lawsuit and Upcoming Deadline – VUZI (finance.yahoo.com) Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Vuzix Corporation (VUZI) (businesswire.com) Vuzix Corp (VUZI) Given Consensus Recommendation of “Hold” by Brokerages (americanbankingnews.com) Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MEDNAX, Farmland Partners, and Vuzix and Encourages Investors to Contact the Firm (feeds.benzinga.com)

    Several brokerages have recently commented on VUZI. ValuEngine raised shares of Vuzix from a “hold” rating to a “buy” rating in a research note on Thursday, June 7th. Zacks Investment Research downgraded shares of Vuzix from a “hold” rating to a “sell” rating in a research note on Thursday, August 16th. Finally, Chardan Capital set a $10.00 price objective on shares of Vuzix and gave the company a “buy” rating in a research note on Friday, August 10th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $9.08.

Best Blue Chip Stocks To Invest In 2019: Colony Bankcorp Inc.(CBAN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about Colony Bankcorp (NASDAQ:CBAN) have trended somewhat positive on Saturday, Accern Sentiment reports. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Colony Bankcorp earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the financial services provider an impact score of 46.0420470648687 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Max Byerly]

    Media headlines about Colony Bankcorp (NASDAQ:CBAN) have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Colony Bankcorp earned a media sentiment score of 0.13 on Accern’s scale. Accern also gave news articles about the financial services provider an impact score of 46.5935973221915 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Stephan Byrd]

    Media stories about Colony Bankcorp (NASDAQ:CBAN) have trended somewhat positive this week, according to Accern. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Colony Bankcorp earned a daily sentiment score of 0.02 on Accern’s scale. Accern also gave news stories about the financial services provider an impact score of 48.3992787299045 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Best Blue Chip Stocks To Invest In 2019: ConocoPhillips(COP)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on ConocoPhillips (COP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    The number of ConocoPhillips (NYSE: COP) shares short fell to 21.01 million from the previous level of 24.44 million. Shares were trading at $69.15, within a 52-week range of $42.27 to $70.15.

  • [By Max Byerly]

    Traders purchased shares of ConocoPhillips (NYSE:COP) on weakness during trading on Friday. $447.22 million flowed into the stock on the tick-up and $180.32 million flowed out of the stock on the tick-down, for a money net flow of $266.90 million into the stock. Of all stocks tracked, ConocoPhillips had the 11th highest net in-flow for the day. ConocoPhillips traded down ($2.77) for the day and closed at $65.36

Hot Medical Stocks To Buy Right Now

You can feel the groundswell in the legal cannabis industry. Not only are the medical benefits of cannabis the topic of conversation almost everywhere – now corporate America is diving in with both feet.

You’ve read about this several times here on Money Morning – and for good reason. Money Morning Defense and Tech Specialist Michael A. Robinson has been talking about the unstoppable trend heading this way for quite some time. And now with legalization in big markets like California and the nation of Canada, the profit potential is becoming enormous.

Hot Medical Stocks To Buy Right Now: AXT Inc(AXTI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on AXT (AXTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58.
    Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009.
    The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613.
    Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65.
    nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results.
    Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303.
    Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    HUYA Inc. (NYSE: HUYA) gained 13.1
  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on AXT (AXTI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get AXT alerts:

    Gallium Arsenide Global Market Players by 2023- Sumitomo Electric, AXT and China Crystal Technologies (newspharmaceuticals.com) TheStreet Downgrades AXT (AXTI) to C+ (americanbankingnews.com) Is this stock is Overbought? AXT, Inc. (AXTI) (stockquote.review) What Investors Should Know? AXT, Inc. (AXTI) (mostvolatilestocks.com) Community rallies around valley high school, putting on its first musical in 20 years (yourcentralvalley.com)

    Several analysts have recently issued reports on AXTI shares. BidaskClub upgraded AXT from a “hold” rating to a “buy” rating in a research note on Wednesday, February 14th. Dougherty & Co reiterated a “buy” rating on shares of AXT in a research note on Thursday, February 22nd. B. Riley decreased their price target on AXT from $8.75 to $8.25 and set a “neutral” rating for the company in a research note on Thursday, February 22nd. Zacks Investment Research downgraded AXT from a “buy” rating to a “hold” rating in a research note on Monday, January 1st. Finally, BWS Financial restated a “buy” rating on shares of AXT in a research note on Tuesday, April 17th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $10.44.

  • [By Logan Wallace]

    Texas Instruments (NASDAQ: TXN) and AXT (NASDAQ:AXTI) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk.

Hot Medical Stocks To Buy Right Now: Agrium Inc.(AGU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news headlines that may have impacted Accern’s rankings:

    Get Agrium alerts:

    Addenda Capital Has Increased Agrium (AGU) Stake By $513880; Guidewire Software (GWRE) Shorts Lowered By … (mtastar.com) Toron Capital Markets Increased By $13.63 Million Its Agrium (AGU) Holding; Isoray (ISR) Has 9 Sentiment (mtastar.com) Global Liquid Potassium Thiosulfate Market 2018 – Agrium, RW Griffin, Plant Food, Hydrite Chemical (satprnews.com) Global NPK Market Analysis 2018 – K+S, Rossosh, Euro Chem, Agrium and Acron (theexpertconsulting.com) Global Controlled-release Fertilizers Market Study 2018-2025 Harrell’s, Agrium, Koch, Knox (assessmentofmarkets.com)

    Agrium traded up $0.41, hitting $115.00, on Friday, according to MarketBeat.com. 833,843 shares of the company’s stock were exchanged, compared to its average volume of 407,078. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.78 and a current ratio of 1.29. Agrium has a 52 week low of $87.82 and a 52 week high of $117.28.

Hot Medical Stocks To Buy Right Now: Home BancShares, Inc.(HOMB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Bankwell Financial Group (NASDAQ: HOMB) and Home Bancshares (NASDAQ:HOMB) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, earnings, risk, profitability, analyst recommendations and dividends.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Home Bancshares (HOMB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    News headlines about Home Bancshares (NASDAQ:HOMB) have trended somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Home Bancshares earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 45.4630889874042 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Stephan Byrd]

    BidaskClub upgraded shares of Home Bancshares (NASDAQ:HOMB) from a strong sell rating to a sell rating in a research report sent to investors on Friday morning.

  • [By Stephan Byrd]

    Zeke Capital Advisors LLC purchased a new stake in shares of Home BancShares (NASDAQ:HOMB) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 8,987 shares of the financial services provider’s stock, valued at approximately $205,000.

Hot Medical Stocks To Buy Right Now: Array BioPharma Inc.(ARRY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Array Biopharma Inc (NASDAQ:ARRY) traded down 7.2% on Friday . The company traded as low as $13.48 and last traded at $13.98. 4,906,836 shares changed hands during trading, an increase of 68% from the average session volume of 2,921,348 shares. The stock had previously closed at $15.06.

  • [By Shane Hupp]

    Eversept Partners LLC reduced its position in shares of Array Biopharma Inc (NASDAQ:ARRY) by 71.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 357,727 shares of the biopharmaceutical company’s stock after selling 880,076 shares during the period. Array Biopharma accounts for about 2.8% of Eversept Partners LLC’s holdings, making the stock its 13th biggest position. Eversept Partners LLC owned approximately 0.17% of Array Biopharma worth $5,838,000 at the end of the most recent reporting period.

  • [By Max Byerly]

    These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:

    Get Array Biopharma alerts:

    $33.36 Million in Sales Expected for Array Biopharma Inc (ARRY) This Quarter (americanbankingnews.com) Array BioPharma Inc. (ARRY) – Oversold Roundup (topdesertsafari.com) Stock under Consideration- Array BioPharma Inc. (ARRY) (topdesertsafari.com) How to Trade these Stock After an unavoidable Selloff: Array BioPharma Inc., (NASDAQ: ARRY), Jagged Peak Energy … (nysetradingnews.com) Shocking Stocks: Sirius XM Holdings Inc., (NASDAQ: SIRI), Array BioPharma Inc., (NASDAQ: ARRY) (globalexportlines.com)

    Shares of ARRY stock opened at $13.86 on Wednesday. The company has a quick ratio of 4.71, a current ratio of 4.71 and a debt-to-equity ratio of 0.42. Array Biopharma has a 1 year low of $8.68 and a 1 year high of $20.21. The firm has a market cap of $2.98 billion, a PE ratio of -18.99 and a beta of 1.27.

  • [By Max Byerly]

    Swiss National Bank raised its holdings in Array Biopharma Inc (NASDAQ:ARRY) by 5.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 325,600 shares of the biopharmaceutical company’s stock after acquiring an additional 16,900 shares during the quarter. Swiss National Bank’s holdings in Array Biopharma were worth $5,314,000 at the end of the most recent quarter.

  • [By Cory Renauer]

    It looks like the benefit-to-risk ratio is off the charts for larotrectinib as well as LOXO-292, but the number of patients with TRK fusion cancers that fail multiple existing treatments is somewhere between 1,500 and 5,000 each year in the U.S. Investors also need to understand that Loxo Oncology licensed its candidates from Array Biopharma (NASDAQ:ARRY) and owes its partner substantial milestone payments and mid-single-digit royalties on any sales they might generate. Loxo has partnered with Bayer AG (NASDAQOTH:BAYRY), and if approved, the German giant will share U.S. profits with Loxo and pay double-digit royalties on sales abroad.

  • [By Keith Speights]

    Three biotechs that have reached this critical milestone with their respective new drugs and await key FDA approval decisions in June are Array BioPharma (NASDAQ:ARRY), GW Pharmaceuticals (NASDAQ:GWPH), and Incyte (NASDAQ:INCY). Here’s what the FDA’s upcoming decisions mean for each of these biotechs.

Hot Medical Stocks To Buy Right Now: Cadence Design Systems, Inc.(CDNS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    State of Alaska Department of Revenue boosted its stake in Cadence Design Systems Inc (NASDAQ:CDNS) by 29.5% in the second quarter, HoldingsChannel.com reports. The fund owned 72,440 shares of the software maker’s stock after buying an additional 16,500 shares during the quarter. State of Alaska Department of Revenue’s holdings in Cadence Design Systems were worth $3,137,000 as of its most recent SEC filing.

  • [By Garrett Baldwin]

    Southwest Airlines Inc. (NYSE: LUV) canceled flights across the country in order to inspect the engines of 40 different airplanes. The inspections come a week after a mid-air engine explosion caused the first U.S. air fatality since 2009. Money Morning Executive Editor Bill Patalon breaks down the aftermath of the accident, and explains what it means for both Southwest and Boeing Co. (NYSE: BA).
    The price of Bitcoin pushed back toward $9,000 as the post-tax season breakout continues for the cryptocurrency markets. The total value of the global cryptocurrency market topped $400 billion this morning, a significant recovery from the massive downturn that occurred in the first quarter. As we explained on Saturday, now may be the best time to buy Bitcoin since July 2013. That month was when Money Morning Defense and Tech Specialist Michael A. Robinson went on live television with a bold prediction for Bitcoin (BTC), which would be followed by 25,351% gains at the peak of the cryptocurrency’s run. Find out where Bitcoin is heading next, right here.
    Three Stocks to Watch Today: GOOGL, LUV, HAS
    Alphabet Inc. (Nasdaq: GOOGL) leads another busy day of earnings reports on Monday. Wall Street anticipates that the online media giant will report earnings per share (EPS) of $9.21 on top of $24.29 billion in revenue.
    Hasbro Inc. (NYSE: HAS) slumped more than 7.6% in pre-market hours after the company reported earnings. The toymaker reported adjusted EPS of $0.10, well short of the $0.33 expected on Wall Street. The firm also reported weaker-than-expected revenue for the quarter. The firm named Toys ‘R Us as a central reason for poor showing – the company recently liquidated its stores, impacting Hasbro Inc.’s (Nasdaq: HAS) bottom lines.
    Look for earnings reports from Halliburton Co. (NYSE: HAL), Alaska Air Group Inc. (NYSE: ALK), Whirlpool Corp. (NYSE: WHR), TD Ameritrade Holding Corp. (Nasdaq: AMTD), Kimberley-Clark Corp. (NYSE: KMB), Cadence Design Syst

  • [By Lisa Levin] Gainers
    Check-Cap Ltd. (NASDAQ: CHEK) shares jumped 104.82 percent to close at $14.87 on Tuesday.
    EVINE Live Inc. (NASDAQ: EVLV) rose 31.25 percent to close at $1.06. The pay-TV home shopping company was named as a potential acquisition target by TechCrunch. According to the publication, Amazon.com, Inc. (NASDAQ: AMZN) is exploring ways of marketing its products and services to consumers beyond the internet.
    SemiLEDs Corporation (NASDAQ: LEDS) shares climbed 27.16 percent to close at $4.26 on Tuesday.
    Atossa Genetics Inc. (NASDAQ: ATOS) gained 27.09 percent to close at $3.80. Atossa Genetics disclosed that it has Received positive interim review from the Independent Safety Committee in Phase 1 Topical endoxifen dose escalation study in men.
    Heidrick & Struggles International, Inc. (NASDAQ: HSII) surged 17.13 percent to close at $37.95 as the company posted upbeat results for its first quarter.
    Santander Consumer USA Holdings Inc. (NYSE: SC) shares gained 15.91 percent to close at $18.21 following upbeat quarterly earnings.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares jumped 15.73 percent to close at $7.58 on Tuesday after declining 1.50 percent on Monday.
    Sanmina Corp (NASDAQ: SANM) shares gained 14.62 percent to close at $31.75 as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Orchids Paper Products Company (NYSE: TIS) jumped 12.86 percent to close at $7.37. Orchids Paper Products is expected to report its Q1 financial results on Wednesday, April 25, 2018.
    Helix Energy Solutions Group, Inc. (NYSE: HLX) rose 12.8 percent to close at $7.05 following strong quarterly results.
    Avid Bioservices, Inc. (NASDAQ: CDMO) rose 12.72 percent to close at $3.81.
    Genprex, Inc. (NASDAQ: GNPX) gained 12.61 percent to close at $5.00.
    Obalon Therapeutics, Inc. (NASDAQ: OBLN) rose 12.39 percent to close at $3.72.
    NextDecade Corporation (NASDAQ: NEXT) shares climbed 11.88 percent to close at $7

Best Oil Stocks To Buy For 2019

January 10, 2017: Markets opened mixed again Tuesday as the blue chips got off to a slow start. The DJIA peake in the middle of the day and slid back into the red with about an hour left this afternoon. The Nasdaq even posted another all-time high at 5,564.25 early this afternoon. Healthcare and financials were leading sectors while real-estate and energy lagged. WTI crude oil for February delivery settled at $50.82 a barrel, down about 2.2% on the day. February gold added less than 0.1% on the day to settle at $1,185.50. Equities were headed for a slightly higher close shortly before the bell as the DJIA traded up 0.05% for the day, the S&P 500 traded up 0.09%, and the Nasdaq Composite traded up 0.38%.

Stocks traded very near the break even line and the closing bell might see some shifts in which side of the line the indexes close on.

The DJIA stock posting the largest daily percentage gain ahead of the close Tuesday was Caterpillar Inc. (NYSE: CAT) which traded up about 1.93% at $94.15. The stock’s 52-week range is $56.36 to $97.40 Volume was about 35% below the daily average of around 4.2 million shares. The company had no specific news Tuesday.

Best Oil Stocks To Buy For 2019: MicroStrategy Incorporated(MSTR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on MicroStrategy (MSTR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Oil Stocks To Buy For 2019: PennantPark Floating Rate Capital Ltd.(PFLT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the headlines that may have impacted Accern’s rankings:

    Get PennantPark Floating Rate alerts:

    PennantPark Floating Rate (PFLT) Plans Monthly Dividend of $0.10 (americanbankingnews.com) PennantPark Floating Rate (PFLT) Stock Rating Upgraded by BidaskClub (americanbankingnews.com) PennantPark Floating Rate (PFLT) to Release Quarterly Earnings on Thursday (americanbankingnews.com) ValuEngine Downgrades PennantPark Floating Rate (PFLT) to Hold (americanbankingnews.com)

    Shares of PFLT stock opened at $13.43 on Tuesday. The firm has a market capitalization of $523.03 million, a price-to-earnings ratio of 12.21 and a beta of 0.56. PennantPark Floating Rate has a one year low of $12.00 and a one year high of $14.65.

Best Oil Stocks To Buy For 2019: Agrium Inc.(AGU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news headlines that may have impacted Accern’s rankings:

    Get Agrium alerts:

    Addenda Capital Has Increased Agrium (AGU) Stake By $513880; Guidewire Software (GWRE) Shorts Lowered By … (mtastar.com) Toron Capital Markets Increased By $13.63 Million Its Agrium (AGU) Holding; Isoray (ISR) Has 9 Sentiment (mtastar.com) Global Liquid Potassium Thiosulfate Market 2018 Agrium, RW Griffin, Plant Food, Hydrite Chemical (satprnews.com) Global NPK Market Analysis 2018 K+S, Rossosh, Euro Chem, Agrium and Acron (theexpertconsulting.com) Global Controlled-release Fertilizers Market Study 2018-2025 Harrell’s, Agrium, Koch, Knox (assessmentofmarkets.com)

    Agrium traded up $0.41, hitting $115.00, on Friday, according to MarketBeat.com. 833,843 shares of the company’s stock were exchanged, compared to its average volume of 407,078. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.78 and a current ratio of 1.29. Agrium has a 52 week low of $87.82 and a 52 week high of $117.28.

Hot Heal Care Stocks To Watch For 2019

Welcome to the world of leather crafting. The world where Tandy Leather Factory (TLF) reigns supreme. Tandy Leather Factory is a niche specialty retailer that dominates the leather crafting market in an undisputed and absolute way.

But Tandy has a problem. It stopped growing in 2014. Sales peaked at $84mil and in 2017 were at $82mil. A lot of people think that this was because the leather crafting market stopped growing. And they are afraid that it will start shrinking. Fortunately, they are wrong.

Tandy Leather Factory IS the US leather crafting market. Tandy doesn’t just sell leather, tools and accessories. Tandy educates and teaches its customers how to use the materials and how to achieve their creations. Every store has regular classes or shows and you can find one near you here.

Hot Heal Care Stocks To Watch For 2019: Agrium Inc.(AGU)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the news headlines that may have impacted Accern’s rankings:

    Get Agrium alerts:

    Addenda Capital Has Increased Agrium (AGU) Stake By $513880; Guidewire Software (GWRE) Shorts Lowered By … (mtastar.com) Toron Capital Markets Increased By $13.63 Million Its Agrium (AGU) Holding; Isoray (ISR) Has 9 Sentiment (mtastar.com) Global Liquid Potassium Thiosulfate Market 2018 Agrium, RW Griffin, Plant Food, Hydrite Chemical (satprnews.com) Global NPK Market Analysis 2018 K+S, Rossosh, Euro Chem, Agrium and Acron (theexpertconsulting.com) Global Controlled-release Fertilizers Market Study 2018-2025 Harrell’s, Agrium, Koch, Knox (assessmentofmarkets.com)

    Agrium traded up $0.41, hitting $115.00, on Friday, according to MarketBeat.com. 833,843 shares of the company’s stock were exchanged, compared to its average volume of 407,078. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.78 and a current ratio of 1.29. Agrium has a 52 week low of $87.82 and a 52 week high of $117.28.

Hot Heal Care Stocks To Watch For 2019: Innodata Inc.(INOD)

Advisors’ Opinion:

  • [By Logan Wallace]

    Luzich Partners LLC lifted its stake in shares of Innodata Inc (NASDAQ:INOD) by 4.9% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,316,550 shares of the technology company’s stock after acquiring an additional 61,944 shares during the period. Innodata accounts for approximately 1.5% of Luzich Partners LLC’s portfolio, making the stock its 12th biggest position. Luzich Partners LLC owned about 5.09% of Innodata worth $1,514,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Innodata (NASDAQ:INOD) will be releasing its Q1 2018 earnings data before the market opens on Tuesday, May 8th.

    Innodata (NASDAQ:INOD) last announced its earnings results on Thursday, March 8th. The technology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $15.66 million for the quarter. Innodata had a negative return on equity of 10.94% and a negative net margin of 8.30%.

  • [By Stephan Byrd]

    Media coverage about Innodata (NASDAQ:INOD) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innodata earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the technology company an impact score of 47.3485759085159 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Hot Heal Care Stocks To Watch For 2019: Discover Financial Services(DFS)

Advisors’ Opinion:

  • [By Elizabeth Aldrich]

    Mastercard Inc. (NYSE: MA), Discover Financial Services (NYSE: DFS), American Express (NYSE: AXP), and Visa Inc. (NYSE: V) all announced that they would stop requiring credit card signatures by April of 2018.Some issuers are dropping the requirement for all purchases made in the U.S. or North America, while American Express is dropping the signature requirement worldwide.

  • [By Max Byerly]

    DFSCoin (CURRENCY:DFS) traded flat against the dollar during the 1-day period ending at 18:00 PM E.T. on May 25th. One DFSCoin coin can currently be purchased for approximately $0.0722 or 0.00000810 BTC on popular exchanges. DFSCoin has a market cap of $1.28 million and $0.00 worth of DFSCoin was traded on exchanges in the last 24 hours. Over the last seven days, DFSCoin has traded down 3.6% against the dollar.

  • [By Joseph Griffin]

    Discover Financial Services (NYSE:DFS) EVP Carlos Minetti sold 3,750 shares of Discover Financial Services stock in a transaction on Monday, July 2nd. The shares were sold at an average price of $69.90, for a total value of $262,125.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

  • [By Matthew Cochrane]

    For years, the major credit card companies — American Express Company (NYSE:AXP), Discover Financial Services (NYSE:DFS), Mastercard Inc (NYSE:MA), and Visa Inc (NYSE:V) — have supported their own digital wallets with varying degrees of success. The problem is, none of them meaningfully appealed to the average consumer. After all, in my own physical wallet, I have one American Express card, one Mastercard, and one Visa. I have no desire to opt into three individual digital wallets to conveniently use the three cards when making online purchases, especially when PayPal’s platform allows me to enter all of my credit cards, across banks and brands, into its own platform.

Best Stocks To Own For 2018

Amazon.com Inc. (NSDQ:AMZN)stock fell by more than 5 % over the last week. There were a series of service announcements last week by Amazons cloud-computing business, AWS, but they also didn’t do much to support the falling AMZN stock. However, AWS re:Invent 2016 has reaffirmed that AWS is one strong reason to buy AMZN stock now. AWS is expected to top $12 billion in revenue this year, compared with $7.9 billion last year. The public cloud pioneer has gone from being the largest, most dominant public cloud service for web developers and startups to providing the most important technology to businesses: the enterprise cloud. Amazon has sustained its aggressive cloud approach, even though competitors like Microsoft (NSDQ:MSFT) and Alphabet (NSDQ:GOOGL) are trying to catch up, using their deep pockets. Here’s why AWS is not slowing down anytime soon and will continue to drive AMZN stock to greater heights.

Best Stocks To Own For 2018: Agrium Inc.(AGU)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Gains are being seen elsewhere as well, except in shares of The Mosaic Company (NYSE: MOS). AgriumInc. (NYSE: AGU) was up almost 3% at $91.95 in late Monday trading, although this one held up much better in the destructive news phase when the alarming news roiled these stocks. The big winner is Intrepid Potash, Inc. (NYSE: IPI), with a gain of 7% to $16.20 in late-Monday trading.

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

  • [By Chad Fraser]

    The agriculture ETF is heavily weighted toward the U.S., with 45.8% of its assets there, but it is geographically diverse, with exposure to countries such as Canada (9.9%), Switzerland (8.5%), Japan (6.7%) and Singapore (5.1%).

    Potash Cartel Breakup Has Weighed on This Agriculture ETF

    The ETF’s unit price declined in the first half of 2013, partly because of the breakup of the Belarusian Potash Company (BPC), through which Russia’s Uralkali, the world’s No. 1 potash producer, and Belaruskali of Belarus distribute their potash. The market is dominated by BPC and Canpotex, owned by Potash Corp. of Saskatchewan (NYSE: POT), Mosaic and Agrium Inc. (NYSE: AGU).

    Together, the two cartels control 70% of global potash exports, so the breakup of BPC will result in a more fractured market, which seems likely to push potash prices lower. Shares of major potash producers fell sharply on the news, as did Market Vectors Agribusiness ETF due to its potash stock holdings, which include Agrium, Potash Corp. and Mosaic.

Best Stocks To Own For 2018: PowerShares S&P SmallCap Information Technology Portfolio(PSCT)

Advisors’ Opinion:

  • [By ]

    Overall, our Game-Changing Stocks portfolio has had a good run this year. Our closed positions for 2017 have, on average, returned 28.5% — a much stronger result than what we’ve seen from the Russell 2000 index or from the PowerShares S&P Small Cap Information Technology Portfolio ETF (Nasdaq: PSCT), which returned 13% and 11% year-to-date, respectively. It’s not a fair comparison, of course, because our closed positions all have different time frames, but it does stress the strong promise of game-changing stocks.

  • [By ]

    On this chart, I plotted the year-to-date performance of the Nasdaq Composite index against two exchange-traded funds (ETFs) — one is an ETF that tracks the small-cap Russell 2000 index, and the other is PowerShares S&P SmallCap Information Technology Portfolio ETF (Nasdaq: PSCT), which serves as a proxy for the types of small-cap tech stocks that are a focus of my premium newsletter, Game-Changing Stocks.

Best Stocks To Own For 2018: Coherent, Inc.(COHR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Rofin-Sinar Technologies (NASDAQ: RSTI) got a boost, shooting up 37 percent to $31.50 as Coherent, Inc. (NASDAQ: COHR) announced its plans to buy Rofin-Sinar Technologies Inc in a deal valued at around $942 million.

Best Stocks To Own For 2018: ePlus Inc.(PLUS)

Advisors’ Opinion:

  • [By Monica Gerson]

    ePlus Inc. (NASDAQ: PLUS) is estimated to post its quarterly earnings at $1.21 per share on revenue of $284.62 million.

    Tilly’s Inc (NYSE: TLYS) is expected to post a quarterly loss at $0.07 per share on revenue of $119.93 million.